The Interplay of Type 1, Type 2, and Type 3 Lymphocytes and Cytokines in Atopic DermatitisKeiichi Yamanaka, Yasutomo Imai, Yui Kono et al.|International Journal of Molecular Sciences|2023Cited by 9
Arteriosclerosis Derived from Cutaneous Inflammation Is Ameliorated by the Deletion of IL-17A and IL-17FTakehisa Nakanishi, Keiichi Yamanaka, Yoshiaki Matsushima et al.|International Journal of Molecular Sciences|2023Cited by 9
Comprehensive Analysis of Type 2 Innate Lymphoid Cell ( <scp>ILC2</scp> ) Heterogeneity and Identification of <scp>CD81</scp> as a Marker for Pathogenic <scp>IL</scp> ‐13 <sup>+</sup> <scp>ILC2s</scp> in Atopic Dermatitis SkinMai Nishimura, Keiichi Yamanaka, Yasutomo Imai et al.|Allergy|2025Cited by 2
Enhanced Innate Immunity Mediated by IL-36α in Atopic Dermatitis and Differences in Cytokine Profiles of Lymphocytes in the Skin and Draining Lymph NodesAyaka Ichikawa, Keiichi Yamanaka, Mai Nishimura et al.|Biomolecules|2025Cited by 1
Differential Profiles of <scp>IL</scp> ‐31‐ and <scp>IL</scp> ‐5/ <scp>IL</scp> ‐13‐Producing Cells Among Helper T Cells, With Subtle <scp>IL</scp> ‐31 Expression in Innate Lymphoid CellsMai Nishimura, Keiichi Yamanaka, Yasutomo Imai et al.|Experimental Dermatology|2025Cited by 0